头孢哌酮与舒巴坦治疗急诊重症感染临床疗效研究
头孢哌酮,,头孢哌酮;舒巴坦;急诊;重症感染;疗效,摘要,关键词,1临床资料,2结果,3讨论,参考文献
摘要:目的 观察头孢哌酮/舒巴坦治疗急诊重症感染的有效性及安全性。 方法 对88例急诊重症感染患者,给予头孢哌酮/舒巴坦治疗,采用静脉滴入方式,每12h给药4.0g,观察其临床疗效及安全性。 结果 头孢哌酮/舒巴坦治疗急诊重症感染的有效率为81.8%,细菌清除率为83.8%,不良反应率为5.7%。 结论 急诊重症感染以革兰阴性菌为主,头孢哌酮/舒巴坦具有高效、安全的特点,可作为急诊重症感染的经验用药。关键词:头孢哌酮;舒巴坦;急诊;重症感染;疗效
Clinical observation on the results in treatment of severe infections with cefoperazone sodium and snlqactam sodium.
ZENG Qi,XING Bai.
(Emergency Outpatient of Hainan Provincial Nongken Bureau Hospital,Haikou570311,Hainan,P.R.Chi-na)
Abstract:Objective To observe the clinical efficacy and safety of cefoperazone/sulbactam in treatment of emergency severe in-fections. Methods A total of88emergency patients with severe infections were given cefoperazone/sulbactam4.0g/12h,iv drip and the clinical efficacy and safetywere observed. Results The clinical cure rates and bacterial clearance rates in the patients with emergency severe infections were81.8%and83.8%,while the adverse drug reactions rates were5.7%. Conclusion Gram-negative bacteria act as major pathogens in the emergency severe infections,cefoperazone/sulbactam is an effective and safe drug in treatment of emergent severe infections. ......
您现在查看是摘要页,全文长 11017 字符。